NuScale Set for Merger Approval

by | Apr 8, 2022

SV / NuScale set merger vote date. A look at next week’s merger and extension votes. And the rest of the day’s news in SPACs.

————————————————-
Free Investor Resources from Boardroom Alpha
—————————————————-
** Podcast: Know Who Drives Return
** Daily SPAC Newsletter
** Full SPAC Listing

Today ends a busy week in SPACland, with two deSPACs and three DAs. Even some deal speculation is back, with onlyFans taking center stage. While regulatory pressures may slow the pace of new issues, this week proves that deals are still getting done. It’s also refreshing to see deSPACs trade with less volatility out of the gate.

deSPACs this week:

  • Gogoro (GGR)

  • MoonLake Immunotherapeutics (MLTX)
  • Mergers this week:

    • PAFO + Caravelle Group
    • ISAA /HYPEBEAST
    • RVAC / Westrock Coffee

    Spring Valley Acquisition Corp. (SV) / Sets NuScale Merger Date

    Spring Valley Acquisition Corp. (SV) Sets 4.28 date for merger approval on NuScale Power. NuScale makes advanced nuclear small modular reactor (SMR) technology. Upon closing, NuScale will trade on the NYSE as “SMR. “

    Elsewhere in SPACs

    On tap for next week is Global SPAC Partners Co. (GLSPT) extension vote. Other upcoming extension votes: GRCY, MACU, BCAC.

    Upcoming Merger and Extension Votes

    Source: Boardroom Alpha

    More from Boardroom Alpha

    For ongoing tracking, analytics, and data on SPACs checkout Boardroom Alpha’s SPAC Data and Analytics service.

    <a href="https://www.boardroomalpha.com/author/joanna/" target="_self">Joanna Makris</a>

    Joanna Makris

    Joanna has been analyzing and investing in emerging technologies for over two decades, having led the Technology, Media, and Telecom research at several global investment banks, including Mizuho Securities and Canaccord Genuity. Navigating stock market volatility since it all began in 2000. Banjo player, artist, and frittata-maker.

    Know Who Drives Return

    Objective, data-driven assessments for every public company director and officer.

    SPAC Analytics & Database

    Comprehensive research and analytics on every SPAC, sponsor, and deal. Real-time alerts, yields, red flags, filings, investors, and much more. API access to institutional grade SPAC database.

    Monthly SPAC Review

    SPAC Market Review – April 2022

    The market is a mess right now. A hawkish Fed and even more cautious SEC are slowing deals….but may raise the bar for more quality SPACs down the line.

    SPAC Market Review – March 2022

    Despite increased scrutiny and apparent investor fatigue, deals are getting done and SPACs remain an attractive path to the public markets.

    SPAC Research & Analysis

    Starting the Week with 2 DAs

    Starting the week off with 2 DAs– oil & gas and battery tech. And the rest of the day’s news in SPACs.

    Comera Gets Approval, with Over 98% Redemptions

    Squeeze alert: OTRA approves its merger with Comera Life Sciences, albeit with some of highest redemptions we’ve seen in a while (98.4%). And the rest of the day’s news in SPACs.

    Know Who Drives Return Podcast

    NYC Pension Funds Want Amazon Accountable for Human Capital

    AMZN stock is performing, but are warehouse workers paying the price? We talk to Assistant NYC Comptroller Michael Garland on the NYC Pension Funds’ move to unseat two Amazon board members responsible for human capital management at the tech giant.

    Boardroom Alpha Daily Read

    Board blow-up at Redbox Entertainment. Mill Road Capital Pushing for a Sale of Big Lots. Happy Earth Day! A perfect time to tune into our latest ESG podcast.

    Disclaimer

    The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

    This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

    None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

    No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.